Peri-Operative Pain and Opioid Use in Opioid-Naïve Patients Following Inpatient Head and Neck Surgery

Pain management is an important consideration for Head and Neck Cancer (HNC) patients as they are at an increased risk of developing chronic opioid use, which can negatively impact both quality of life and survival outcomes. This retrospective cohort study aimed to evaluate pain, opioid use and opio...

Full description

Bibliographic Details
Main Authors: Danielle R. Trakimas, Carlos Perez-Heydrich, Rajarsi Mandal, Marietta Tan, Christine G. Gourin, Carole Fakhry, Wayne M. Koch, Jonathon O. Russell, Ralph P. Tufano, David W. Eisele, Peter S. Vosler
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.857083/full
_version_ 1818535823883108352
author Danielle R. Trakimas
Carlos Perez-Heydrich
Rajarsi Mandal
Marietta Tan
Christine G. Gourin
Carole Fakhry
Wayne M. Koch
Jonathon O. Russell
Ralph P. Tufano
David W. Eisele
Peter S. Vosler
author_facet Danielle R. Trakimas
Carlos Perez-Heydrich
Rajarsi Mandal
Marietta Tan
Christine G. Gourin
Carole Fakhry
Wayne M. Koch
Jonathon O. Russell
Ralph P. Tufano
David W. Eisele
Peter S. Vosler
author_sort Danielle R. Trakimas
collection DOAJ
description Pain management is an important consideration for Head and Neck Cancer (HNC) patients as they are at an increased risk of developing chronic opioid use, which can negatively impact both quality of life and survival outcomes. This retrospective cohort study aimed to evaluate pain, opioid use and opioid prescriptions following HNC surgery. Participants included patients undergoing resection of a head and neck tumor from 2019–2020 at a single academic center with a length of admission (LOA) of at least 24 h. Exclusion criteria were a history of chronic pain, substance-use disorder, inability to tolerate multimodal analgesia or a significant post-operative complication. Subjects were compared by primary surgical site: Neck (neck dissection, thyroidectomy or parotidectomy), Mucosal (resection of tumor of upper aerodigestive tract, excluding oropharynx), Oropharyngeal (OP) and Free flap (FF). Average daily pain and total daily opioid consumption (as morphine milligram equivalents, MME) and quantity of opioids prescribed at discharge were compared. A total of 216 patients met criteria. Pain severity and daily opioid consumption were comparable across groups on post-operative day 1, but both metrics were significantly greater in the OP group on the day prior to discharge (DpDC) (5.6 (1.9–8.6), p < 0.05; 49 ± 44 MME/day, p < 0.01). The quantity of opioids prescribed at discharge was associated with opioid consumption on the DpDC only in the Mucosal and FF groups, which had longer LOA (6–7 days) than the Neck and OP groups (1 day, p < 0.001). Overall, 65% of patients required at least one dose of an opioid on the DpDC, yet 76% of patients received a prescription for an opioid medication at discharge. A longer LOA (aOR = 0.82, 95% CI: 0.63–0.98) and higher Charlson Comorbidity Index (aOR = 0.08, 95% CI: 0.01–0.48) were negatively associated with receiving an opioid prescription at the time of discharge despite no opioid use on the DpDC, respectively. HNC patients, particularly those with shorter LOA, may be prescribed opioids in excess of their post-operative needs, highlighting the need the for improved pain management algorithms in this patient population. Future work aims to use prospective surveys to better define post-operative and outpatient pain and opioid requirements following HNC surgery.
first_indexed 2024-12-11T18:30:04Z
format Article
id doaj.art-dd1c5498a1084dcd83a426276a71a5f8
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-12-11T18:30:04Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-dd1c5498a1084dcd83a426276a71a5f82022-12-22T00:54:57ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402022-07-011310.3389/fpsyt.2022.857083857083Peri-Operative Pain and Opioid Use in Opioid-Naïve Patients Following Inpatient Head and Neck SurgeryDanielle R. TrakimasCarlos Perez-HeydrichRajarsi MandalMarietta TanChristine G. GourinCarole FakhryWayne M. KochJonathon O. RussellRalph P. TufanoDavid W. EiselePeter S. VoslerPain management is an important consideration for Head and Neck Cancer (HNC) patients as they are at an increased risk of developing chronic opioid use, which can negatively impact both quality of life and survival outcomes. This retrospective cohort study aimed to evaluate pain, opioid use and opioid prescriptions following HNC surgery. Participants included patients undergoing resection of a head and neck tumor from 2019–2020 at a single academic center with a length of admission (LOA) of at least 24 h. Exclusion criteria were a history of chronic pain, substance-use disorder, inability to tolerate multimodal analgesia or a significant post-operative complication. Subjects were compared by primary surgical site: Neck (neck dissection, thyroidectomy or parotidectomy), Mucosal (resection of tumor of upper aerodigestive tract, excluding oropharynx), Oropharyngeal (OP) and Free flap (FF). Average daily pain and total daily opioid consumption (as morphine milligram equivalents, MME) and quantity of opioids prescribed at discharge were compared. A total of 216 patients met criteria. Pain severity and daily opioid consumption were comparable across groups on post-operative day 1, but both metrics were significantly greater in the OP group on the day prior to discharge (DpDC) (5.6 (1.9–8.6), p < 0.05; 49 ± 44 MME/day, p < 0.01). The quantity of opioids prescribed at discharge was associated with opioid consumption on the DpDC only in the Mucosal and FF groups, which had longer LOA (6–7 days) than the Neck and OP groups (1 day, p < 0.001). Overall, 65% of patients required at least one dose of an opioid on the DpDC, yet 76% of patients received a prescription for an opioid medication at discharge. A longer LOA (aOR = 0.82, 95% CI: 0.63–0.98) and higher Charlson Comorbidity Index (aOR = 0.08, 95% CI: 0.01–0.48) were negatively associated with receiving an opioid prescription at the time of discharge despite no opioid use on the DpDC, respectively. HNC patients, particularly those with shorter LOA, may be prescribed opioids in excess of their post-operative needs, highlighting the need the for improved pain management algorithms in this patient population. Future work aims to use prospective surveys to better define post-operative and outpatient pain and opioid requirements following HNC surgery.https://www.frontiersin.org/articles/10.3389/fpsyt.2022.857083/fullhead and neck surgerypost-operative analgesiaopioidsprescriptionspain
spellingShingle Danielle R. Trakimas
Carlos Perez-Heydrich
Rajarsi Mandal
Marietta Tan
Christine G. Gourin
Carole Fakhry
Wayne M. Koch
Jonathon O. Russell
Ralph P. Tufano
David W. Eisele
Peter S. Vosler
Peri-Operative Pain and Opioid Use in Opioid-Naïve Patients Following Inpatient Head and Neck Surgery
Frontiers in Psychiatry
head and neck surgery
post-operative analgesia
opioids
prescriptions
pain
title Peri-Operative Pain and Opioid Use in Opioid-Naïve Patients Following Inpatient Head and Neck Surgery
title_full Peri-Operative Pain and Opioid Use in Opioid-Naïve Patients Following Inpatient Head and Neck Surgery
title_fullStr Peri-Operative Pain and Opioid Use in Opioid-Naïve Patients Following Inpatient Head and Neck Surgery
title_full_unstemmed Peri-Operative Pain and Opioid Use in Opioid-Naïve Patients Following Inpatient Head and Neck Surgery
title_short Peri-Operative Pain and Opioid Use in Opioid-Naïve Patients Following Inpatient Head and Neck Surgery
title_sort peri operative pain and opioid use in opioid naive patients following inpatient head and neck surgery
topic head and neck surgery
post-operative analgesia
opioids
prescriptions
pain
url https://www.frontiersin.org/articles/10.3389/fpsyt.2022.857083/full
work_keys_str_mv AT daniellertrakimas perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery
AT carlosperezheydrich perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery
AT rajarsimandal perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery
AT mariettatan perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery
AT christineggourin perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery
AT carolefakhry perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery
AT waynemkoch perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery
AT jonathonorussell perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery
AT ralphptufano perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery
AT davidweisele perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery
AT petersvosler perioperativepainandopioiduseinopioidnaivepatientsfollowinginpatientheadandnecksurgery